| Data harmonization for collaborative research among MS registries: a case study in employment A Salter, A Stahmann, D Ellenberger, F Fneish, WJ Rodgers, R Middleton, ... Multiple Sclerosis Journal 27 (2), 281-289, 2021 | 26 | 2021 |
| Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts A Setyawati, MSH Wahyuningsih, DAA Nugrahaningsih, C Effendy, ... Saudi Journal of Biological Sciences 28 (12), 7257-7268, 2021 | 18 | 2021 |
| SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study N Frahm, F Fneish, D Ellenberger, J Haas, M Loebermann, T Parciak, ... The Lancet Regional Health–Europe 22, 2022 | 13 | 2022 |
| Aggressive multiple sclerosis: a matter of measurement and timing D Ellenberger, P Flachenecker, F Fneish, N Frahm, K Hellwig, F Paul, ... Brain 143 (11), e97-e97, 2020 | 13 | 2020 |
| Management of MS Patients Treated With Daclizumab–a Case Series of 267 Patients PS Rommer, K Berger, D Ellenberger, F Fneish, A Simbrich, A Stahmann, ... Frontiers in Neurology 11, 552993, 2020 | 11 | 2020 |
| Characteristics of secondary progressive multiple sclerosis: disease activity and provision of care in Germany–a registry-based/multicentric cohort study N Frahm, D Ellenberger, F Fneish, K Christoph, C Warnke, UK Zettl, ... Multiple Sclerosis and Related Disorders 56, 103281, 2021 | 6 | 2021 |
| Frequency and predictors of relapses following SARS-CoV-2 vaccination in patients with multiple sclerosis: interim results from a longitudinal observational study N Frahm, F Fneish, D Ellenberger, J Haas, M Löbermann, M Peters, ... Journal of Clinical Medicine 12 (11), 3640, 2023 | 4 | 2023 |
| Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS registry N Frahm, F Fneish, D Ellenberger, P Flachenecker, F Paul, C Warnke, ... Neurology and Therapy 11 (1), 319-336, 2022 | 4 | 2022 |
| Improving risk assessment in clinical trials: toward a systematic risk-based monitoring approach F Fneish, F Schaarschmidt, G Fortwengel Current Therapeutic Research 95, 100643, 2021 | 4 | 2021 |
| Comparison of non-commercial risk based monitoring tools by their application on clinical trial protocols F Fneish, D Limaye, V Struever, G Fortwengel Am J Biomed Sci & Res 8 (3), 2020 | 4 | 2020 |
| Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry F Fneish, D Ellenberger, N Frahm, A Stahmann, G Fortwengel, ... Therapeutic Innovation & Regulatory Science 57 (6), 1217-1228, 2023 | 2 | 2023 |
| Rolle von Komorbiditäten bei Multipler Sklerose nicht unterschätzen N Frahm, F Fneish, D Ellenberger, M Peters, H Temmes, A STAHMANN Neuro Transmitter 33, 40-4, 2022 | 2 | 2022 |
| Patient benefit of clinical research in diversely advanced African developing countries V Strüver, S Ali, F Fneish, G Fortwengel Current Therapeutic Research 96, 100656, 2022 | 1 | 2022 |
| The temporal development of clinical research in emerging countries V Strüver, F Fneish, R Muche, G Fortwengel Am J Clin Exp Med 9, 1-7, 2021 | 1 | 2021 |
| Employment outcomes in paediatric onset MS A Stahmann, P Flachenecker, F Fneish, C Kleinschnitz, D Pöhlau, ... ECTRIMS Congress, 2019 | 1 | 2019 |
| Clinical Research and Standard of Care—An Unresolved Question? N Tornieporth, F Fneish, G Fortwengel Current Therapeutic Research 78 (Supplement), S4-S5, 2016 | 1 | 2016 |
| P473 M Peters, D Ellenberger, F Fneish, A Stahmann, T Friede, K Berger, ... Age 1 (14), 3.2, 1985 | 1 | 1985 |
| Prediction intervals for overdispersed Poisson data and their application in medical and pre-clinical quality control M Menssen, M Dammann, F Fneish, D Ellenberger, F Schaarschmid arXiv preprint arXiv:2404.05282, 2024 | | 2024 |
| Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry N Frahm, D Ellenberger, A Stahmann, F Fneish, D Lüftenegger, ... Therapeutic Advances in Neurological Disorders 17, 17562864241239740, 2024 | | 2024 |
| Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations A Stahmann, E Craig, D Ellenberger, F Fneish, N Frahm, RA Marrie, ... Therapeutic Advances in Neurological Disorders 17, 17562864241233044, 2024 | | 2024 |
